<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Complications of stroke: An overview</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Complications of stroke: An overview</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Complications of stroke: An overview</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Koto Ishida, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Scott E Kasner, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">John F Dashe, MD, PhD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Oct 17, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Complications of acute stroke are common. They increase the risk of poor clinical outcomes. Preventative strategies and treatments are available and should be used when appropriate.</p><p>The prognosis of stroke is reviewed separately:</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/14086.html" rel="external">"Overview of ischemic stroke prognosis in adults"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/1136.html" rel="external">"Lacunar infarcts", section on 'Prognosis'</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/1101.html" rel="external">"Intracranial large artery atherosclerosis: Treatment and prognosis", section on 'Prognosis'</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/1090.html" rel="external">"Cryptogenic stroke and embolic stroke of undetermined source (ESUS)", section on 'Prognosis'</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/14083.html" rel="external">"Stroke after cardiac catheterization", section on 'Prognosis'</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/6215.html" rel="external">"Ischemic stroke in children: Management and prognosis", section on 'Prognosis'</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/114253.html" rel="external">"Stroke in the newborn: Management and prognosis", section on 'Prognosis'</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/1084.html" rel="external">"Spontaneous intracerebral hemorrhage: Acute treatment and prognosis", section on 'Early prognosis'</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/1127.html" rel="external">"Aneurysmal subarachnoid hemorrhage: Treatment and prognosis", section on 'Prognosis'</a>.)</p><p></p><p class="headingAnchor" id="H2"><span class="h1">MEDICAL COMPLICATIONS</span><span class="headingEndMark"> — </span>The rates of reported medical complications of stroke are high  (<a class="graphic graphic_table graphicRef52076" href="/z/d/graphic/52076.html" rel="external">table 1</a> and <a class="graphic graphic_table graphicRef68148" href="/z/d/graphic/68148.html" rel="external">table 2</a>) [<a href="#rid1">1-5</a>]. Serious complications include pneumonia, urinary tract infection, gastrointestinal bleeding, myocardial infarction, deep vein thrombosis, and pulmonary embolism.</p><p>Incidence rates and populations vary across studies, but improving care may be reducing some complication rates. In one prospective longitudinal study, the frequency of one or more medical complications within the first week after stroke declined from 2003 to 2013 by 36 percent [<a href="#rid6">6</a>]. In an analysis from the United States of the 2007-2019 National Inpatient Sample database of over 5,750,000 adults admitted with a primary diagnosis of acute ischemic stroke, infectious complications decreased while noninfectious complications increased over the study period [<a href="#rid7">7</a>].</p><p>The presence of any in-hospital medical complication, many of which are preventable, has been associated with a significantly increased risk for 30-day readmission (adjusted hazard ratio 1.68; 95% CI 1.04-2.73) [<a href="#rid8">8</a>].</p><p class="headingAnchor" id="H51492085"><span class="h2">Dysphagia</span><span class="headingEndMark"> — </span>Dysphagia is a common complication of stroke and is a major risk factor for developing aspiration pneumonia. Dysphagia related to stroke is more precisely characterized as oropharyngeal dysphagia, defined by swallowing impairment of the upper digestive tract. This definition has been extended to capture impairments in swallowing efficiency and safety, including delays in the timing of movements, reduced range of movements, and frank aspiration [<a href="#rid9">9</a>]. Aspiration in this population is usually a sign of severe dysphagia, and refers to abnormal entry of fluid, particulate exogenous substances, or endogenous secretions into the airways.</p><p>These observations are supported by a systematic review of 24 studies that evaluated oropharyngeal dysphagia and aspiration in adult patients with stroke [<a href="#rid9">9</a>]. In pooled analysis of studies with sufficient data, the risk of pneumonia was increased with dysphagia compared with no dysphagia (relative risk [RR] 3.17, 95% CI 2.07-4.87) and especially with aspiration compared with no aspiration (RR 11.56, 95% CI 3.36-39.77).</p><p>The incidence of dysphagia after stroke was lowest when identified by screening methods, mainly water swallow (37 to 45 percent) [<a href="#rid9">9</a>]. The incidence was intermediate when identified by a trained swallowing clinician (51 to 55 percent), and it was highest when identified by instrumental testing, mainly videofluoroscopy (64 to 78 percent). The dysphagia rates may have been overestimated by instrumental testing, which can reveal movement patterns that reflect the normal effects of aging; these were not distinguished from pathologic dysphagia by the definitions used in the studies.</p><p>Independent predictors of dysphagia on initial presentation include facial palsy, aphasia, age greater than 70, stroke severity (higher scores on the National Institutes of Health Stroke Scale [NIHSS]), impaired pharyngeal response, incomplete oral clearance, and palatal weakness or asymmetry [<a href="#rid10">10-12</a>]. Dysphagia usually improves spontaneously with return of safe swallowing function by two weeks in approximately 90 percent of patients [<a href="#rid9">9,13,14</a>]. However, a significant minority of patients have persistent dysphagia.</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Screening for dysphagia</strong> – We evaluate swallowing function using a water swallow test at the time of admission for all patients with acute stroke before administering oral medications or food [<a href="#rid15">15</a>]. The water swallow test is simple and quick to perform, although the specific method of testing can vary in different stroke centers. The patient, who must be awake and alert, is positioned upright in bed as high as tolerated between 30 to 90 degrees and instructed to drink 3 ounces (90 cc) of water from a cup by mouth (use of a straw is permitted) slowly and steadily without stopping [<a href="#rid16">16-18</a>]. The test is passed if the patient can drink the entire volume of water without coughing or choking during or immediately (eg, within one minute) after swallowing. The test is failed if the patient develops coughing, choking, gurgling, or is unable to drink the entire volume of water in a single or sequential swallows.</p><p></p><p class="bulletIndent1">Videofluoroscopy with modified <a class="drug drug_general" data-topicid="9180" href="/z/d/drug information/9180.html" rel="external">barium</a> swallow can be performed once the patient is stable in order to assess the severity of oropharyngeal dysfunction and risk of aspiration. (See  <a class="medical medical_review" href="/z/d/html/2237.html" rel="external">"Oropharyngeal dysphagia: Clinical features, diagnosis, and management", section on 'Videofluoroscopic modified barium swallow'</a>.)</p><p></p><p class="bulletIndent1">In a prospective, multicenter study, use of a formal screening protocol for dysphagia (eg, water swallow test) for all patients admitted with stroke was associated with a significantly decreased risk of aspiration pneumonia compared with no formal screen (adjusted odds ratio 0.10, 95% CI 0.03-0.45) [<a href="#rid19">19</a>]. The pneumonia rates at sites with and without a formal dysphagia screen were 2.4 versus 5.4 percent, for an absolute risk reduction of 3 percent.</p><p></p><p class="bulletIndent1">Bedside tests to screen for swallowing dysfunction are useful but have a lower sensitivity compared with more comprehensive testing [<a href="#rid20">20-22</a>]. In a 2016 systematic review and meta-analysis of 11 studies and 770 patients with stroke, the water swallow test for aspiration had a sensitivity of 64 to 79 percent and a specificity of 61 to 81 percent [<a href="#rid21">21</a>]. One study found that the best bedside predictors of aspiration to thin liquid were spontaneous cough during test swallows and the overall sense of the presence of aspiration by the examiner [<a href="#rid23">23</a>]. A 2012 systematic review found that cough or voice change in response to bedside water swallow test had a low to moderate sensitivity and moderate to high specificity for predicting aspiration [<a href="#rid24">24</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Preventing aspiration</strong> – Prevention of aspiration for patients with acute stroke includes initial nil per os (NPO) status for those who may be at risk for aspiration and subsequent dietary modifications for those who have persistent dysphagia. Intravenous hydration with normal <a class="drug drug_general" data-topicid="9929" href="/z/d/drug information/9929.html" rel="external">saline</a> should be administered to maintain volume status [<a href="#rid25">25</a>]. (See  <a class="medical medical_review" href="/z/d/html/2237.html" rel="external">"Oropharyngeal dysphagia: Clinical features, diagnosis, and management"</a>.)</p><p></p><p class="bulletIndent1">Patients with acute stroke who cannot take food and fluids orally due to persistent dysphagia, altered mental status, and/or mechanical ventilation should receive nutrition and hydration via nasogastric, nasoduodenal, or percutaneous endoscopic gastrostomy tube feedings while undergoing efforts to restore swallowing [<a href="#rid26">26</a>]. In most cases, a nasogastric tube should be placed within 48 hours of stroke onset if enteral nutrition is likely to be needed for less than four weeks; nasogastric tube placement may be placed sooner if necessary to administer oral medications.</p><p></p><p class="bulletIndent1">Ideally, percutaneous gastrostomy tube placement can be deferred for two to four weeks to determine whether spontaneous recovery of swallowing will develop and to allow time to discuss the risks and benefits of gastrostomy tube insertion. However, observational data from the United States suggest that the median time to placement is closer to seven days for patients with stroke [<a href="#rid27">27</a>]. Early gastrostomy tube placement is probably driven in part by requirements for disposition, since nasogastric tube feeding is not an option at many acute rehabilitation facilities. (See  <a class="medical medical_review" href="/z/d/html/1617.html" rel="external">"Nutrition support in intubated critically ill adult patients: Initial evaluation and prescription"</a> and  <a class="medical medical_review" href="/z/d/html/2568.html" rel="external">"Gastrostomy tubes: Uses, patient selection, and efficacy in adults"</a> and  <a class="medical medical_review" href="/z/d/html/2583.html" rel="external">"Enteral feeding: Gastric versus post-pyloric"</a>.)</p><p></p><p class="headingAnchor" id="H363716276"><span class="h2">Venous thromboembolism</span><span class="headingEndMark"> — </span>Venous thromboembolism (VTE) encompasses deep vein thrombosis (DVT) and pulmonary embolism, which is potentially life threatening. VTE prophylaxis is indicated for all patients with acute stroke who have restricted mobility. The approach to prevention and treatment of VTE is reviewed in detail separately. (See  <a class="medical medical_review" href="/z/d/html/121857.html" rel="external">"Prevention and treatment of venous thromboembolism in patients with acute stroke"</a>.)</p><p class="headingAnchor" id="H1679226139"><span class="h2">Fever and infection</span></p><p class="headingAnchor" id="H1022053800"><span class="h3">Burden of fever</span><span class="headingEndMark"> — </span>Fever is a common complication of stroke, may worsen outcomes, and can sometimes lead to clinically nonindicated and potentially harmful antimicrobial use. In one retrospective report of 1361 patients hospitalized with acute ischemic stroke, one or more episodes of fever affected approximately 36 percent of patients [<a href="#rid28">28</a>].</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Effect on outcomes</strong> – Fever is associated with unfavorable outcomes in human studies of stroke [<a href="#rid28">28-31</a>]. In a meta-analysis of over 14,000 patients with neurologic injury, including hemorrhagic and/or ischemic stroke, fever was associated with increased mortality rates, greater disability, more dependence, worse functional outcome, greater severity, and longer intensive care unit and hospital stays [<a href="#rid29">29</a>]. These results were consistent for overall pooled data and for subgroups limited to studies of patients with hemorrhagic, ischemic, or all stroke types. A subsequent meta-analysis found that fever within 24 hours of hospital admission in patients with ischemic stroke was associated with a two-fold increase in the odds of mortality at one month after stroke onset [<a href="#rid31">31</a>].</p><p></p><p class="bulletIndent1">Fever may contribute to brain injury in patients with an acute stroke. This concept has been demonstrated in animal models in which ischemic injury is increased in the presence of elevated temperature. Hyperthermia may act via several mechanisms to worsen cerebral ischemia [<a href="#rid32">32,33</a>]:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Enhanced release of neurotransmitters</p><p class="bulletIndent2"><span class="glyph">•</span>Exaggerated oxygen radical production</p><p class="bulletIndent2"><span class="glyph">•</span>More extensive blood-brain barrier breakdown</p><p class="bulletIndent2"><span class="glyph">•</span>Increased numbers of potentially damaging ischemic depolarizations in the focal ischemic penumbra</p><p class="bulletIndent2"><span class="glyph">•</span>Impaired recovery of energy metabolism and enhanced inhibition of protein kinases</p><p class="bulletIndent2"><span class="glyph">•</span>Worsening of cytoskeletal proteolysis</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Management</strong> – Temperature reduction to achieve normothermia is the preferred strategy for the management of fever. (See  <a class="medical medical_review" href="/z/d/html/1126.html" rel="external">"Initial assessment and management of acute stroke", section on 'Fever'</a>.)</p><p></p><p class="bulletIndent1">Prophylactic antibiotics may reduce the rate of overall infection in patients with acute stroke but do not reduce mortality or improve functional outcome [<a href="#rid34">34</a>].</p><p></p><p class="headingAnchor" id="H2004774164"><span class="h3">Pneumonia</span><span class="headingEndMark"> — </span>Pneumonia develops in 3 to 10 percent of patients with acute stroke [<a href="#rid4">4,6,7,35,36</a>]. Stroke-related pneumonia is associated with a higher mortality and a poorer long-term outcome [<a href="#rid4">4,35,37,38</a>].</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Risk factors and causes</strong> – Risk factors for in-hospital pneumonia include older age, dysarthria, dysphagia, aphasia, stroke severity, cognitive impairment, use of gastric acid suppressive medications, and an abnormal water swallow test [<a href="#rid39">39-42</a>].</p><p></p><p class="bulletIndent1">Aspiration is the cause of approximately 60 percent of poststroke pneumonia [<a href="#rid2">2</a>]. Aspiration pneumonia refers to the pulmonary consequences resulting from the abnormal entry of fluid, particulate exogenous substances, or endogenous secretions into the lower airways. Most pneumonia arises following the "aspiration" of microorganisms from the oral cavity or nasopharynx. Aspiration pneumonia following stroke is usually due to stroke-related dysphagia (ie, impairment of motor and sensory mechanisms involved in deglutition) or to a decreased level of consciousness that results in compromise of the cough reflex and glottic closure. (See <a class="local">'Dysphagia'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Prevention</strong> – Measures to prevent aspiration pneumonia in patients with dysphagia include initial nil per os (NPO; nothing by mouth) status and subsequent dietary modifications for those who have persistent dysphagia. (See  <a class="medical medical_review" href="/z/d/html/2237.html" rel="external">"Oropharyngeal dysphagia: Clinical features, diagnosis, and management"</a>.)</p><p></p><p class="bulletIndent1">Screening on admission for swallowing difficulty is an important measure to prevent pneumonia in patients with acute stroke, as discussed above. (See <a class="local">'Dysphagia'</a> above.)</p><p></p><p class="bulletIndent1">Additional preventive measures include patient mobilization when neurologically stable and good pulmonary care [<a href="#rid25">25</a>]. For intubated patients, risk reduction measures include daily assessment for potential extubation, minimizing sedation, suctioning of secretions, elevating the head of the bed when possible, and maintaining ventilator circuits. (See  <a class="medical medical_review" href="/z/d/html/6995.html" rel="external">"Risk factors and prevention of hospital-acquired and ventilator-associated pneumonia in adults"</a>.)</p><p></p><p class="bulletIndent1">Given the apparent increased risk of hospital-acquired pneumonia associated with the use of histamine-2 receptor antagonists and proton pump inhibitors, we avoid agents that suppress gastric acid in patients who are not at high risk of developing a stress ulcer or stress gastritis. Prophylactic antibiotics for patients with acute stroke do not reduce the incidence of poststroke pneumonia or improve functional outcomes [<a href="#rid43">43,44</a>]. Several other interventions (eg, positioning, drugs, oral hygiene, tube feeding, influenza vaccination, pneumococcal vaccination) have been proposed to prevent aspiration in hospitalized and nonhospitalized older adult patients. However, no clinical trials have evaluated the utility of these measures specifically in patients with stroke. (See  <a class="medical medical_review" href="/z/d/html/7024.html" rel="external">"Aspiration pneumonia in adults"</a> and  <a class="medical medical_review" href="/z/d/html/6995.html" rel="external">"Risk factors and prevention of hospital-acquired and ventilator-associated pneumonia in adults"</a> and  <a class="medical medical_review" href="/z/d/html/7021.html" rel="external">"Pneumococcal vaccination in adults"</a> and  <a class="medical medical_review" href="/z/d/html/7007.html" rel="external">"Seasonal influenza vaccination in adults"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Diagnosis and management</strong> – The diagnosis and management of hospital acquired pneumonia is reviewed elsewhere. (See  <a class="medical medical_review" href="/z/d/html/6993.html" rel="external">"Treatment of hospital-acquired and ventilator-associated pneumonia in adults"</a>.)</p><p></p><p class="headingAnchor" id="H3703724699"><span class="h3">Urinary tract infection</span><span class="headingEndMark"> — </span>Urinary tract infection occurs in 11 to 15 percent of patients followed for up to three months after acute stroke [<a href="#rid1">1,4,7</a>] and constitutes a serious complication (ie, prolonged, immediately life threatening, or resulting in hospitalization or death) in approximately 1 percent [<a href="#rid2">2</a>]. Urinary tract infection remains a common complication when patients are followed for up to 30 months [<a href="#rid1">1</a>].</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Risk factors and causes</strong> – In a meta-analysis, the main risk factors for urinary tract infection were female sex, older age, higher modified Rankin Scale score (a measure of poststroke disability), and postvoid residual volume &gt;100 mL [<a href="#rid45">45</a>].</p><p></p><p class="bulletIndent1">It is common practice to place indwelling bladder catheters in patients with stroke due to immobility, incontinence, urinary retention, or convenience. However, placement of an indwelling bladder catheter is an important risk factor for infection, and the duration of catheterization is directly related to risk of urinary tract infection [<a href="#rid46">46</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Prevention</strong> – The use of indwelling urinary catheters should be avoided whenever possible [<a href="#rid15">15</a>]. The use of external catheter systems (ie, condom catheters for men, adhesive urinary pouches for women) or intermittent catheterizations are alternatives that may be associated with a lower risk of urinary tract infections compared with an indwelling urethral catheter. However, supporting data are scant. (See  <a class="medical medical_review" href="/z/d/html/8090.html" rel="external">"Placement and management of urinary bladder catheters in adults"</a> and  <a class="medical medical_review" href="/z/d/html/8095.html" rel="external">"Complications of urinary bladder catheters and preventive strategies"</a> and  <a class="medical medical_review" href="/z/d/html/8054.html" rel="external">"Catheter-associated urinary tract infection in adults"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Diagnosis and management</strong> – We test for urinary tract infection if patients have signs of infection (eg, fever, leukocytosis), unexplained altered mental status, or suggestive symptoms. Classic manifestations of urinary tract infection include dysuria, urinary frequency or urgency, suprapubic pain, or flank pain, often accompanied by fever, chills, and/or elevated peripheral white blood cell count. Urine cultures are important in diagnosing catheter-related urinary tract infection. Most patients with symptomatic bacteriuria (ie, urinary tract infection) have bacterial culture growth ≥10<sup>5</sup> colony forming units (CFU)/mL or fungal growth in urine. (See  <a class="medical medical_review" href="/z/d/html/8054.html" rel="external">"Catheter-associated urinary tract infection in adults", section on 'Clinical features'</a>.)</p><p></p><p class="bulletIndent1">Indwelling urinary catheters and older age are associated with an increased risk of asymptomatic bacteriuria. Treatment of asymptomatic bacteriuria does not improve patient outcomes and increases the likelihood of emergence of resistant bacteria. Thus, with few exceptions, screening and treatment for asymptomatic bacteriuria in catheterized patients is not indicated. (See  <a class="medical medical_review" href="/z/d/html/8054.html" rel="external">"Catheter-associated urinary tract infection in adults", section on 'Asymptomatic bacteriuria'</a>.)</p><p></p><p class="bulletIndent1">After the diagnosis is made, treatment options should be tailored to the culture results and regional organism sensitivities. Bladder catheter management, methods to reduce the risk of infection associated with indwelling catheters, and treatment of catheter-associated urinary tract infection are reviewed elsewhere. (See  <a class="medical medical_review" href="/z/d/html/8054.html" rel="external">"Catheter-associated urinary tract infection in adults"</a>.)</p><p></p><p class="bulletIndent1">Issues related to acute cystitis, recurrent urinary tract infection, and acute pyelonephritis are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/8063.html" rel="external">"Acute simple cystitis in adult and adolescent females"</a> and  <a class="medical medical_review" href="/z/d/html/8059.html" rel="external">"Acute simple cystitis in adult and adolescent males"</a> and  <a class="medical medical_review" href="/z/d/html/8053.html" rel="external">"Recurrent simple cystitis in women"</a> and  <a class="medical medical_review" href="/z/d/html/16109.html" rel="external">"Acute complicated urinary tract infection (including pyelonephritis) in adults and adolescents"</a>.)</p><p></p><p class="headingAnchor" id="H3792990858"><span class="h2">Cardiac complications</span><span class="headingEndMark"> — </span>Myocardial infarction, cardiac arrhythmias, and neurogenic cardiac injury are potential short- and long-term complications of acute stroke [<a href="#rid47">47</a>].</p><p class="headingAnchor" id="H1410741822"><span class="h3">Myocardial infarction</span><span class="headingEndMark"> — </span>All patients with acute stroke should have electrocardiography (ECG) and troponin level on admission, and continuous cardiac monitoring for at least the first 24 hours of admission to detect arrhythmias, particularly atrial fibrillation [<a href="#rid15">15,48</a>]. Data from the modern era suggest that myocardial infarction (MI) occurs in approximately 1 to 2.5 percent of patients with acute stroke during initial hospitalization and is associated with poor outcome [<a href="#rid2">2,6,7,49</a>].</p><p>MI should be suspected in patients who have chest pain, shortness of breath, new heart failure, or sudden cardiac arrest. The diagnosis of MI is supported by the presence of ST and/or T wave changes on ECG, positive cardiac biomarkers, or hemodynamic abnormalities. (See  <a class="medical medical_review" href="/z/d/html/52.html" rel="external">"Diagnosis of acute myocardial infarction"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Elevated cardiac enzymes</strong> – Cardiac troponin is the standard blood-based test to confirm the diagnosis of acute myocardial infarction (see  <a class="medical medical_review" href="/z/d/html/52.html" rel="external">"Diagnosis of acute myocardial infarction", section on 'Definitions'</a>). However, troponin is not specific for acute thrombotic occlusion of a coronary artery, the most common precursor to acute myocardial infarction. Increased blood concentrations of cardiac troponin can also be seen in a variety of other diseases  (<a class="graphic graphic_table graphicRef54910" href="/z/d/graphic/54910.html" rel="external">table 3</a>), including acute stroke. In such cases, elevation of troponin and other cardiac enzymes after acute stroke may be related to stroke-induced autonomic dysfunction or other types of nonischemic myocardial injury. (See  <a class="medical medical_review" href="/z/d/html/1469.html" rel="external">"Elevated cardiac troponin concentration in the absence of an acute coronary syndrome", section on 'Acute stroke'</a>.)</p><p></p><p class="bulletIndent1">Limited retrospective data suggest that elevated troponin on admission for acute stroke is associated with embolic stroke of unknown source (ESUS) and cardioembolic stroke [<a href="#rid50">50</a>], but further studies are needed to confirm this finding.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>ECG abnormalities</strong> – The ECG is an essential diagnostic test for patients with possible or established myocardial ischemia, injury, or infarction (see  <a class="medical medical_review" href="/z/d/html/2095.html" rel="external">"Electrocardiogram in the diagnosis of myocardial ischemia and infarction"</a>). Abnormalities are manifest in the ST-segment, T wave, and QRS complex. However, the ECG may be normal or nonspecific in a patient with either myocardial ischemia or MI. Furthermore, ECG abnormalities that appear to represent myocardial ischemia or infarction may be present for other reasons. ECG changes may occur in the setting of stroke, likely mediated by the autonomic nervous system, particularly related to subarachnoid hemorrhage. These include QT prolongation, T wave abnormalities, ST segment elevation, and aberrant Q waves. These abnormalities may also represent pre-existing coronary disease [<a href="#rid51">51</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Management</strong> – The management of patients with suspected acute coronary syndrome (MI, unstable angina) is reviewed separately. (See  <a class="medical medical_review" href="/z/d/html/184.html" rel="external">"Initial evaluation and management of suspected acute coronary syndrome (myocardial infarction, unstable angina) in the emergency department"</a> and  <a class="medical medical_review" href="/z/d/html/66.html" rel="external">"Overview of the acute management of ST-elevation myocardial infarction"</a> and  <a class="medical medical_review" href="/z/d/html/68.html" rel="external">"Overview of the acute management of non-ST-elevation acute coronary syndromes"</a>.)</p><p></p><p class="headingAnchor" id="H1936864324"><span class="h3">Arrhythmias</span><span class="headingEndMark"> — </span>Cardiac arrhythmias are frequently present in the setting of acute stroke [<a href="#rid52">52,53</a>], stressing the importance of continuous cardiac monitoring in the initial phase of stroke management. In many cases, the cardiac rhythm disturbances likely were present prior to the stroke and were not directly related to the stroke [<a href="#rid54">54</a>]. Symptomatic arrhythmias generally require management in an intensive care unit setting with cardiology consultation.</p><p>In a prospective study of 501 patients with acute stroke, potentially serious cardiac arrhythmia events occurred in 126 patients (25 percent) during the first 72 hours after admission to a monitored stroke unit [<a href="#rid52">52</a>]. Tachycardia occurred mainly with atrial fibrillation; other causes included focal atrial tachycardia, undetermined supraventricular tachycardia, ventricular ectopy, nonsustained ventricular tachycardia, and atrial flutter. Bradyarrhythmias were caused by atrial fibrillation, Mobitz type II atrioventricular block, asystole/sinoatrial block, and complete atrioventricular block.</p><p class="headingAnchor" id="H596371422"><span class="h3">Neurogenic cardiac damage</span><span class="headingEndMark"> — </span>A wide spectrum of regional left ventricular wall motion abnormalities, typically but not always reversible, can occur with subarachnoid hemorrhage and less often with other types of stroke [<a href="#rid55">55</a>]. Some patients develop a pattern of transient apical left ventricular dysfunction that mimics myocardial infarction, but in the absence of significant coronary artery disease [<a href="#rid56">56</a>]. This condition is known as takotsubo cardiomyopathy. (See  <a class="medical medical_review" href="/z/d/html/1130.html" rel="external">"Aneurysmal subarachnoid hemorrhage: Clinical manifestations and diagnosis"</a> and  <a class="medical medical_review" href="/z/d/html/3494.html" rel="external">"Clinical manifestations and diagnosis of stress (takotsubo) cardiomyopathy"</a>.)</p><p>Stroke-induced cardiac damage is uncommon but is well described [<a href="#rid57">57,58</a>]. It is unlikely that the only mechanism explaining cardiac damage after acute stroke is the presence of underlying coronary disease, particularly since signs of cardiac damage may occur in patients with subarachnoid hemorrhage, who are often young and without underlying heart disease. In addition, the rapid appearance and disappearance of the ST changes argue against macrovascular factors and in favor of neural factors [<a href="#rid59">59,60</a>]. Myocardial injury in these cases is most likely the result of a centrally mediated release of catecholamines caused by stroke-related brain injury. This type of cardiac injury is similar to stress cardiomyopathy (also called takotsubo cardiomyopathy) characterized by transient regional systolic dysfunction of the left ventricle (LV), mimicking myocardial infarction, but in the absence of angiographic evidence of obstructive coronary artery disease or acute plaque rupture. (See  <a class="medical medical_review" href="/z/d/html/3494.html" rel="external">"Clinical manifestations and diagnosis of stress (takotsubo) cardiomyopathy"</a>.)</p><p>Cardiac myofibrillar degeneration has been described in patients who die from acute stroke, and is histologically identical to the cardiac lesions of catecholamine infusion, "voodoo death," hypothalamic stimulation, or reperfusion of transiently ischemic cardiac muscle [<a href="#rid57">57</a>]. The myofibrillar degeneration occurs in the vicinity of the cardiac nerves, and not in the macrovascular distribution seen in patients with coronary disease [<a href="#rid57">57,61</a>]. The lesion also differs from the necrosis seen in coronary disease because it is visible within minutes of onset, and the cells die in a hypercontracted state with contraction bands, associated mononuclear infiltration, and early calcification.</p><p>Accumulating experimental and clinical evidence suggests that stroke involving the insular cortex may be associated with adverse cardiac outcomes including repolarization abnormalities, arrhythmias, neurogenic cardiac damage, heart failure, and sudden death [<a href="#rid62">62-68</a>]. The presumed biologic basis for this association is the role of the insular cortex in the autonomic control of cardiovascular function [<a href="#rid63">63,67-75</a>].</p><p class="headingAnchor" id="H3422052666"><span class="h2">Acute kidney injury</span><span class="headingEndMark"> — </span>In an analysis of the 2007-2019 National Inpatient Sample of over 5,750,000 adults admitted for acute ischemic stroke in the United States, the prevalence of acute kidney injury was approximately 10 percent, making it one of the most common complications [<a href="#rid7">7</a>]. Among patients on mechanical ventilation, the prevalence of AKI was approximately 25 percent.</p><p class="headingAnchor" id="H3643446365"><span class="h2">Pulmonary complications</span><span class="headingEndMark"> — </span>Serious pulmonary complications of stroke include pneumonia, neurogenic pulmonary edema, and the need for intubation and mechanical ventilation [<a href="#rid76">76</a>].</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Pneumonia</strong> – Pneumonia is a common cause of fever within the first 48 hours of acute stroke. Aspiration is the most frequent cause of poststroke pneumonia, and it is usually due to stroke-related dysphagia or to decreased level of consciousness. (See <a class="local">'Pneumonia'</a> above and <a class="local">'Dysphagia'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Need for mechanical ventilation</strong> – Intubation and mechanical ventilation of patients with ischemic stroke is usually performed to treat pulmonary edema or for inability to protect the airway. Additional indications include partial airway obstruction, hypoventilation, and aspiration pneumonia. (See  <a class="medical medical_review" href="/z/d/html/1640.html" rel="external">"Overview of initiating invasive mechanical ventilation in adults in the intensive care unit"</a> and  <a class="medical medical_review" href="/z/d/html/1628.html" rel="external">"Clinical and physiologic complications of mechanical ventilation: Overview", section on 'Increased intracranial pressure'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Neurogenic pulmonary edema</strong> – Neurogenic pulmonary edema (NPE) is reviewed here briefly and discussed in detail elsewhere. (See  <a class="medical medical_review" href="/z/d/html/1610.html" rel="external">"Neurogenic pulmonary edema"</a>.)</p><p></p><p class="bulletIndent1">Neurogenic pulmonary edema (NPE) is an increase in interstitial and alveolar fluid that occurs in the setting of head trauma, seizures, or stroke, particularly subarachnoid hemorrhage  (<a class="graphic graphic_table graphicRef57483" href="/z/d/graphic/57483.html" rel="external">table 4</a>). NPE most often develops abruptly and progresses quickly after the onset of the neurologic insult. The typical patient with NPE is dyspneic, tachycardic, and hypertensive, with bilateral rales. Most cases of NPE resolve spontaneously and are well tolerated, but the condition can be fatal in severe cases. Treatment of NPE is largely supportive and directed mainly towards treatment of the underlying neurologic condition.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Abnormal respiratory patterns</strong> – Abnormal respiratory patterns may complicate stroke; these include Cheyne-Stokes breathing, periodic breathing, apneustic breathing, central sleep apnea, ataxic breathing, and failure of automatic breathing  (<a class="graphic graphic_figure graphicRef74371" href="/z/d/graphic/74371.html" rel="external">figure 1</a>). (See  <a class="medical medical_review" href="/z/d/html/5113.html" rel="external">"Disorders of ventilatory control"</a>.)</p><p></p><p class="headingAnchor" id="H1242987768"><span class="h2">Sleep-related breathing disorders</span><span class="headingEndMark"> — </span>The relationship of sleep-disordered breathing (including both obstructive sleep apnea and central sleep apnea syndrome) as a possible risk factor for stroke and as a possible complication of stroke is discussed separately. (See  <a class="medical medical_review" href="/z/d/html/7716.html" rel="external">"Sleep-related breathing disorders and stroke"</a>.)</p><p class="headingAnchor" id="H19"><span class="h2">Gastrointestinal bleeding</span><span class="headingEndMark"> — </span>Gastrointestinal (GI) hemorrhage affects 1.1 to 3 percent of patients with acute stroke [<a href="#rid2">2,7,77,78</a>]. Patients with acute stroke and GI hemorrhage have worse outcomes, with higher rates of dependency and mortality. Overt GI bleeding may be severe or even life threatening and manifests with hematemesis, melena, or hematochezia. Occult GI bleeding (ie, no visible evidence of bleeding) is generally less serious; it is suspected in the setting of iron deficiency anemia or a positive fecal occult blood test.</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Risk factors</strong> – Retrospective data from various studies suggest that risk factors for GI hemorrhage include older age, severe stroke, posterior circulation stroke, infection, history of hypertension, hepatic cirrhosis, prestroke dependence, and a history of peptic ulcer disease or cancer predating the incident stroke [<a href="#rid77">77-80</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Prevention</strong> – GI stress ulcer prophylaxis with proton pump inhibitors or H2 antagonists is effective for reducing overt GI bleeding but may increase the risk of nosocomial pneumonia. Therefore, stress ulcer prophylaxis is not used routinely for patients with acute stroke but is reserved for select patients who need intensive care unit management or are otherwise at high risk. Stress ulcer prophylaxis is reasonable for patients who have risk factors such as intensive care unit stay lasting more than one week, mechanical ventilation for &gt;48 hours, sepsis, hereditary or acquired coagulopathy, including therapeutic anticoagulation, a history of GI ulceration or bleeding within the past year, occult gastrointestinal bleeding lasting ≥6 days, or treatment with high-dose glucocorticoids. (See  <a class="medical medical_review" href="/z/d/html/1611.html" rel="external">"Stress ulcers in the intensive care unit: Diagnosis, management, and prevention", section on 'High-risk patients'</a>.)</p><p></p><p class="bulletIndent1">There is some evidence that enteral nutrition alone may reduce the risk of overt GI bleeding due to stress ulceration and that stress ulcer prophylaxis may be ineffective or harmful among patients who are receiving enteral nutrition, as reviewed separately. (See  <a class="medical medical_review" href="/z/d/html/1611.html" rel="external">"Stress ulcers in the intensive care unit: Diagnosis, management, and prevention", section on 'High-risk patients'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Management</strong> – Withholding of antiplatelet or anticoagulant therapy in the setting of clinically overt GI bleeding should be individualized. The management of GI bleeding is discussed in detail elsewhere. (See  <a class="medical medical_review" href="/z/d/html/2548.html" rel="external">"Approach to acute upper gastrointestinal bleeding in adults"</a> and  <a class="medical medical_review" href="/z/d/html/2547.html" rel="external">"Approach to acute lower gastrointestinal bleeding in adults"</a> and  <a class="medical medical_review" href="/z/d/html/2544.html" rel="external">"Evaluation of occult gastrointestinal bleeding"</a>.)</p><p></p><p class="headingAnchor" id="H2475321346"><span class="h2">Urinary incontinence</span><span class="headingEndMark"> — </span>Urinary incontinence is a common problem after stroke and is associated with poor functional outcome and mortality, perhaps because it is a marker of stroke severity [<a href="#rid81">81-85</a>]. Urinary incontinence is present in 32 to 79 percent of patients on admission, and 25 to 28 percent at discharge [<a href="#rid86">86</a>]. Data from prospective population-based studies suggest that in previously continent patients, new urinary incontinence is found in 35 to 40 percent of patients at 7 to 10 days after acute stroke [<a href="#rid85">85</a>]. The prevalence of poststroke incontinence decreases with time. Of a group of 95 patients with incontinence 7 to 10 days after stroke, incontinence persisted at three months, one year, and two years in 36, 24, and 13 percent, respectively [<a href="#rid87">87</a>].</p><p>The most frequent urodynamic finding is detrusor hyperreflexia [<a href="#rid88">88</a>]. The loss of inhibitory input from higher neurologic centers is thought to cause this hyperreflexia leading to urinary urgency, frequency, and urge incontinence. In addition to detrusor hyperreflexia, detrusor hyporeflexia or areflexia may also occur following stroke, leading to overflow incontinence. Detrusor-sphincter dyssynergia is an uncommon phenomenon in patients with recent stroke, unlike other neurologic disorders associated with incontinence.</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Risk factors</strong> – Risk factors for the development of urinary incontinence in patients with stroke include hemiparesis, depression, cognitive impairment, age &gt;75 years, dysphagia, visual field defect, and large infarcts (cortical plus subcortical area involvement) [<a href="#rid89">89,90</a>]. Other factors contributing to urinary retention include the use of anticholinergic drugs, diabetic cystopathy, and bladder outlet obstruction.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Prevention</strong> – Indwelling bladder catheter placement should be avoided when possible to decrease the risks of nosocomial infection, which is a potential contributing factor for urinary incontinence.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Evaluation and management</strong> – Practitioners can easily overlook urinary incontinence if patients or nursing staff are not directly queried. Diagnosis of the type of incontinence and appropriate treatment can be coordinated with a urologist. Detrusor hyperreflexia can be treated with scheduled voiding, tailored fluid restriction, and anticholinergic drugs. There is little evidence to support specific interventions for urinary incontinence after stroke [<a href="#rid91">91</a>]. The evaluation and treatment of urinary incontinence is discussed in detail separately. (See  <a class="medical medical_review" href="/z/d/html/14611.html" rel="external">"Urinary incontinence in men"</a> and  <a class="medical medical_review" href="/z/d/html/6874.html" rel="external">"Female urinary incontinence: Evaluation"</a> and  <a class="medical medical_review" href="/z/d/html/6881.html" rel="external">"Female urinary incontinence: Treatment"</a>.)</p><p></p><p class="headingAnchor" id="H21"><span class="h2">Falls and bone fractures</span><span class="headingEndMark"> — </span>Falls have been cited as one of the most common complications of acute stroke [<a href="#rid1">1,92,93</a>]. In a prospective multicenter study of 311 patients followed up to 30 months after stroke, falls occurred in 25 percent and were associated with serious injury in 5 percent [<a href="#rid1">1</a>]. Hip fractures represent 45 percent of poststroke fractures and are two to four times more common in the population with stroke compared with an age-matched reference population [<a href="#rid94">94</a>]. A retrospective case-control study found that the rate of falls among hospitalized patients with acute ischemic stroke was only 2.3 percent [<a href="#rid95">95</a>].</p><p>Hospitalized patients with stroke not only have skeletal "unloading" secondary to bed rest, but they also have disuse of the paretic limbs. These factors predispose patients to bone resorption. Patients who can ambulate early after stroke appear to lose bone density only on the paretic side (hemiosteoporosis), while those who are not ambulatory lose bone mineral density on both sides. Relearning to walk by two months has been associated with diminished bone density loss compared with remaining nonambulatory [<a href="#rid96">96</a>].</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Risk factors</strong> – Patients with cognitive impairment, neglect, anosognosia, and/or polypharmacy may be at especially high risk for falls [<a href="#rid25">25</a>]. Other risk factors for poststroke falls include a history of prior fracture or fall, malnutrition, depression, osteoarthritis, older age, and female sex [<a href="#rid93">93</a>]. </p><p></p><p class="bulletIndent1">Most fractures after stroke occur on the paretic side and are secondary to accidental falls [<a href="#rid94">94,97</a>]. Poststroke patients tend to fall toward the paretic side and lack ample protective responses, such as outstretching an arm, putting them at higher risk for fractures. (See  <a class="medical medical_review" href="/z/d/html/3012.html" rel="external">"Falls in older persons: Risk factors and patient evaluation"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Prevention</strong> – Fall precautions should be implemented for all patients with acute stroke; specific elements include measures to reduce the risk of delirium, the use of bed and chair alarms, minimal use of mechanical restraints, and use of ceiling lifts to assist with transfers [<a href="#rid25">25</a>]. However, the evidence supporting these measures for fall prevention in patients with stroke is limited [<a href="#rid98">98</a>].</p><p></p><p class="headingAnchor" id="H23"><span class="h2">Depression</span><span class="headingEndMark"> — </span>Poststroke depression is common, although difficult to quantify precisely due to methodologic differences among studies. A 2013 meta-analysis, with pooled data from 43 studies and over 20,000 patients, found that the prevalence of depression observed at any time after stroke was 29 percent (95% CI 25-32 percent) [<a href="#rid99">99</a>]. There was no significant difference in prevalence rates of depression at different time points after stroke. In pooled data from 10 studies with over 16,000 patients, predictors of poststroke depression were disability, prestroke depression, cognitive impairment, stroke severity, and anxiety.</p><p>In a later case-control study that compared over 135,000 patients with stroke and no diagnosis of depression at baseline with 145,000 matched controls, the incidence of depression during the first two years after hospitalization was significantly higher for the group with stroke (25 versus 8 percent) [<a href="#rid100">100</a>].</p><p>Depression after stroke is correlated with poorer functional outcomes [<a href="#rid101">101</a>], although causation cannot be inferred from this. Nonetheless, when patients are matched for initial functional outcome, remission of depression is associated with a better functional outcome at three and six months than continued depression [<a href="#rid102">102</a>]. There appears to be a relationship between depression and 12- and 24-month mortality, but confounders likely exist [<a href="#rid103">103</a>].</p><p>The theory that depression is more commonly associated with left than with right hemisphere strokes and with lesions of the left anterior brain than with other regions [<a href="#rid104">104</a>] is not supported by the data. In a systematic review of 48 studies, the relative risk of depression after a left versus right hemisphere stroke was 0.95 (95% CI 0.83-1.10) [<a href="#rid105">105</a>]. Similarly, the risk of depression after a left anterior lesion compared with all other brain lesions was 1.17 (0.87-1.62).</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Risk factors</strong> – Possible risk factors for poststroke depression include physical disability, stroke severity, prestroke depression, cognitive impairment, and insufficient family and social support [<a href="#rid101">101</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Prevention</strong> – It is unclear whether interventions to prevent poststroke depression are effective. A 2020 systematic review identified 49 trials involving 3342 subjects that evaluated prevention of poststroke depression [<a href="#rid106">106</a>]. The review concluded that there was only very low certainty evidence that pharmacologic or psychologic therapies reduced the prevalence of poststroke depression.</p><p></p><p class="bulletIndent1">Further study in rigorous clinical trials is needed to determine the utility of antidepressant interventions for preventing depression after acute stroke.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Assessment</strong> – There are many depression scales that can be used to assess depression after stroke. The single question "Do you often feel sad or depressed?" was found to have a sensitivity and specificity of 86 and 78 percent, respectively when used against the Montgomery-Asberg depression rating in screening for poststroke depression [<a href="#rid107">107</a>]. (See  <a class="medical medical_review" href="/z/d/html/1721.html" rel="external">"Unipolar depression in adults: Assessment and diagnosis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Treatment</strong> – Major depression is a treatable illness that responds to a variety of therapeutic interventions, and it is likely that the standard approach to the treatment of depression in adults is generalizable to patients with poststroke depression. The initial treatment of depression is discussed separately. (See  <a class="medical medical_review" href="/z/d/html/1725.html" rel="external">"Unipolar major depression in adults: Choosing initial treatment"</a>.)</p><p></p><p class="bulletIndent1">There is no definitive evidence to guide the specific choice of therapy for patients with poststroke depression [<a href="#rid101">101</a>]. The effectiveness of pharmacotherapy, psychotherapy, or combined use of these modalities for poststroke depression is not established, but accumulating evidence suggests that these interventions are beneficial. For patients able to engage in physical activity, exercise may be helpful. (See  <a class="medical medical_review" href="/z/d/html/1725.html" rel="external">"Unipolar major depression in adults: Choosing initial treatment"</a>.)</p><p></p><p class="headingAnchor" id="H869188616"><span class="h2">Poststroke fatigue</span><span class="headingEndMark"> — </span>Poststroke fatigue lacks a consensus definition, but encompasses a subjective feeling of exhaustion and lack of physical or mental energy and/or an increased need for rest that interferes with usual activities [<a href="#rid108">108,109</a>]. It is generally distinguished from poststroke depression, although the two may exist concurrently. The pathophysiology of poststroke fatigue is unsettled; possible factors include disturbances in cortical excitability, inflammation, and genes that modulate inflammation [<a href="#rid108">108,110,111</a>].</p><p>The prevalence of poststroke fatigue ranges from 23 to 75 percent in different studies [<a href="#rid112">112</a>]; the wide range is likely due to variation in definitions, patient populations, assessment scales, and time points (most often six months after stroke onset) among different reports [<a href="#rid108">108</a>]. Some studies distinguish between early poststroke fatigue (up to two to three months after stroke onset) and late poststroke fatigue (more than three months after stroke onset) [<a href="#rid110">110,111,113</a>]. However, it is unclear whether these two phases of fatigue are distinct [<a href="#rid110">110</a>].</p><p>There is no consensus about the need to screen for poststroke fatigue, and no proven therapy is available [<a href="#rid114">114</a>]. In a randomized trial of 36 patients with poststroke fatigue more than three months after stroke, <a class="drug drug_general" data-topicid="10157" href="/z/d/drug information/10157.html" rel="external">modafinil</a> was more effective than placebo for reducing fatigue and improving quality of life [<a href="#rid115">115</a>], but definitive conclusions are precluded by the small size of the trial, and further study is needed. Other suggested interventions for poststroke fatigue include promoting physical activity and exercise, identifying and treating depression, anxiety, pain, and sleep disturbances, and avoiding sedating drugs and excessive alcohol [<a href="#rid108">108,109</a>].</p><p class="headingAnchor" id="H4211430240"><span class="h1">NEUROLOGIC COMPLICATIONS</span></p><p class="headingAnchor" id="H1767965874"><span class="h2">Intracranial complications</span><span class="headingEndMark"> — </span>Intracranial complications of acute stroke include the development of cerebral edema, symptomatic hemorrhagic transformation of ischemic stroke, elevated intracranial pressure, and hydrocephalus. Cerebral edema with space-occupying mass effect develops in a minority of ischemic stroke but can cause neurologic deterioration and life-threatening herniation.</p><p>The clinical features and management of intracranial complications of stroke are reviewed separately for each major type of stroke:</p><p class="bulletIndent1"><span class="glyph">●</span>Ischemic stroke (see  <a class="medical medical_review" href="/z/d/html/1096.html" rel="external">"Malignant cerebral hemispheric infarction with swelling and risk of herniation"</a>)</p><p class="bulletIndent1"><span class="glyph">●</span>Intracerebral hemorrhage (see  <a class="medical medical_review" href="/z/d/html/1084.html" rel="external">"Spontaneous intracerebral hemorrhage: Acute treatment and prognosis"</a>)</p><p class="bulletIndent1"><span class="glyph">●</span>Subarachnoid hemorrhage (see  <a class="medical medical_review" href="/z/d/html/1127.html" rel="external">"Aneurysmal subarachnoid hemorrhage: Treatment and prognosis"</a>)</p><p></p><p>The general management of elevated intracranial pressure is discussed elsewhere. (See  <a class="medical medical_review" href="/z/d/html/1659.html" rel="external">"Evaluation and management of elevated intracranial pressure in adults"</a>.)</p><p class="headingAnchor" id="H3851505734"><span class="h2">Early neurologic deterioration</span><span class="headingEndMark"> — </span>Early neurologic deterioration (END) after acute stroke occurs in 2 to 38 percent of patients and is associated with poor outcomes [<a href="#rid116">116-119</a>]. The wide range in the frequency of END probably reflects differences in the patient populations studied and variations in the definitions of END.</p><p>The mechanisms of END are heterogeneous. Common causes include extension of the infarct into surrounding areas of hypoperfused brain tissue, hematoma expansion of intracerebral hemorrhage, delayed cerebral ischemia associated with subarachnoid hemorrhage, other intracranial complications (eg, progressive cerebral edema, hemorrhagic transformation of ischemic stroke) and toxic-metabolic encephalopathy due to medical complications (eg, concomitant infection; cardiovascular, pulmonary, and/or renal dysfunction) [<a href="#rid116">116,120-122</a>]. Interventions that address the underlying cause may help to improve outcome. However, the cause of END is often unclear [<a href="#rid116">116</a>].</p><p class="headingAnchor" id="H3547237950"><span class="h2">Seizures</span><span class="headingEndMark"> — </span>Early seizures after stroke are relatively uncommon but are associated with poor outcome. Risk factors include worse stroke severity and cortical involvement. Poststroke seizures are reviewed elsewhere. (See  <a class="medical medical_review" href="/z/d/html/2220.html" rel="external">"Overview of the management of epilepsy in adults", section on 'Poststroke seizures'</a>.)</p><p class="headingAnchor" id="H3924897786"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/z/d/html/105370.html" rel="external">"Society guideline links: Stroke in adults"</a>.)</p><p class="headingAnchor" id="H28960802"><span class="h1">INFORMATION FOR PATIENTS</span><span class="headingEndMark"> — </span>UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.)</p><p class="bulletIndent1"><span class="glyph">●</span>Basics topics (see  <a class="medical medical_basics" href="/z/d/html/15328.html" rel="external">"Patient education: Stroke (The Basics)"</a> and  <a class="medical medical_basics" href="/z/d/html/16266.html" rel="external">"Patient education: Recovery after stroke (The Basics)"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Beyond the Basics topics (see  <a class="medical medical_patient" href="/z/d/html/726.html" rel="external">"Patient education: Stroke symptoms and diagnosis (Beyond the Basics)"</a>)</p><p></p><p class="headingAnchor" id="H27"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span>Medical complications after ischemic stroke are common  (<a class="graphic graphic_table graphicRef52076" href="/z/d/graphic/52076.html" rel="external">table 1</a> and <a class="graphic graphic_table graphicRef68148" href="/z/d/graphic/68148.html" rel="external">table 2</a>) and influence outcome. Potentially serious complications include pneumonia, urinary tract infection, gastrointestinal bleeding, myocardial infarction, deep vein thrombosis, and pulmonary embolism. (See <a class="local">'Medical complications'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>We evaluate swallowing function using a water swallow test at the time of admission for all patients with acute stroke before administering oral medications or food. Prevention of aspiration in patients with dysphagia includes initial nil per os (NPO; nothing by mouth) status for those who may be at risk for aspiration and subsequent dietary modifications for those who have persistent dysphagia. Patients with acute stroke who cannot take food and fluids orally should receive nutrition and hydration via nasogastric, nasoduodenal, or percutaneous endoscopic gastrostomy tube feedings while undergoing efforts to restore swallowing. (See <a class="local">'Dysphagia'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>VTE prophylaxis is indicated for all patients with acute stroke who have restricted mobility, as reviewed separately. (See  <a class="medical medical_review" href="/z/d/html/121857.html" rel="external">"Prevention and treatment of venous thromboembolism in patients with acute stroke"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Pneumonia and urinary tract infection are the two most common infectious complications of acute stroke. Screening on admission for swallowing difficulty is an important measure to prevent pneumonia in patients with acute stroke, as discussed above. Measures to prevent aspiration pneumonia in patients with dysphagia include initial NPO status and subsequent dietary modifications for those who have persistent dysphagia. Placement of an indwelling bladder catheter is an important risk factor for urinary tract infection and should be avoided if possible. (See <a class="local">'Pneumonia'</a> above and <a class="local">'Urinary tract infection'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Myocardial infarction, cardiac arrhythmias, and neurogenic cardiac injury are potential complications of acute stroke. All patients with acute stroke should have ECG and troponin level on admission, and continuous cardiac monitoring at least the first 24 hours of admission. (See <a class="local">'Cardiac complications'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Besides pneumonia, serious pulmonary complications of stroke include neurogenic pulmonary edema and the need for intubation and mechanical ventilation. (See <a class="local">'Pulmonary complications'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Gastrointestinal (GI) bleeding is one of the more common complications of acute stroke. Risk factors include older age, severe stroke, and a history of peptic ulcer disease or cancer predating the incident stroke. GI stress ulcer prophylaxis with proton pump inhibitors or histamine-2 antagonists is not used routinely for patients with acute stroke but is reserved for select patients who need intensive care unit management. (See <a class="local">'Gastrointestinal bleeding'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Urinary incontinence after stroke is associated with poor functional outcome and mortality, perhaps because it is a marker of stroke severity. in previously continent patients, new urinary incontinence is found in 35 to 40 percent of patients at 7 to 10 days after acute stroke. The prevalence of poststroke incontinence decreases with time. (See <a class="local">'Urinary incontinence'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Falls after acute stroke and are associated with serious injury in 5 percent of patients. Fall precautions should be implemented for all patients with stroke, particularly those with hemiparesis, cognitive impairment, neglect, anosognosia, and/or polypharmacy. (See <a class="local">'Falls and bone fractures'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The prevalence of poststroke depression is 18 to 61 percent. Stroke severity, physical disability, and cognitive impairment are likely risk factors. The effectiveness of pharmacotherapy, psychotherapy, or combined use of these modalities for poststroke depression is not established, but accumulating evidence suggests that these interventions are beneficial. Thus, the standard approach to the treatment of depression is likely to be generalizable to patients with poststroke depression. (See <a class="local">'Depression'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Neurologic complications of acute stroke encompass intracranial morbidities (progressive cerebral edema, symptomatic hemorrhagic transformation of ischemic stroke, elevated intracranial pressure, hydrocephalus), neurologic deterioration, and (uncommonly) seizures. (See <a class="local">'Neurologic complications'</a> above.)</p><p></p><p class="headingAnchor" id="H51491763"><span class="h1">ACKNOWLEDGMENT</span><span class="headingEndMark"> — </span>The UpToDate editorial staff acknowledges Dr. Teresa Jacobs, who contributed to earlier versions of this topic review.</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Langhorne P, Stott DJ, Robertson L, et al. Medical complications after stroke: a multicenter study. Stroke 2000; 31:1223.</a></li><li><a class="nounderline abstract_t">Johnston KC, Li JY, Lyden PD, et al. Medical and neurological complications of ischemic stroke: experience from the RANTTAS trial. RANTTAS Investigators. Stroke 1998; 29:447.</a></li><li><a class="nounderline abstract_t">Indredavik B, Rohweder G, Naalsund E, Lydersen S. Medical complications in a comprehensive stroke unit and an early supported discharge service. Stroke 2008; 39:414.</a></li><li><a class="nounderline abstract_t">Ingeman A, Andersen G, Hundborg HH, et al. In-hospital medical complications, length of stay, and mortality among stroke unit patients. Stroke 2011; 42:3214.</a></li><li><a class="nounderline abstract_t">Hong KS, Kang DW, Koo JS, et al. Impact of neurological and medical complications on 3-month outcomes in acute ischaemic stroke. Eur J Neurol 2008; 15:1324.</a></li><li><a class="nounderline abstract_t">Bovim MR, Askim T, Lydersen S, et al. Complications in the first week after stroke: a 10-year comparison. BMC Neurol 2016; 16:133.</a></li><li><a class="nounderline abstract_t">Ahmed R, Mhina C, Philip K, et al. Age- and Sex-Specific Trends in Medical Complications After Acute Ischemic Stroke in the United States. Neurology 2023; 100:e1282.</a></li><li><a class="nounderline abstract_t">Shah SV, Corado C, Bergman D, et al. Impact of Poststroke Medical Complications on 30-Day Readmission Rate. J Stroke Cerebrovasc Dis 2015; 24:1969.</a></li><li><a class="nounderline abstract_t">Martino R, Foley N, Bhogal S, et al. Dysphagia after stroke: incidence, diagnosis, and pulmonary complications. Stroke 2005; 36:2756.</a></li><li><a class="nounderline abstract_t">Mann G, Hankey GJ. Initial clinical and demographic predictors of swallowing impairment following acute stroke. Dysphagia 2001; 16:208.</a></li><li><a class="nounderline abstract_t">Labeit B, Michou E, Hamdy S, et al. The assessment of dysphagia after stroke: state of the art and future directions. Lancet Neurol 2023; 22:858.</a></li><li><a class="nounderline abstract_t">Lin WC, Huang CY, Lee LF, et al. Initial National Institute of Health Stroke Scale to Early Predict the Improvement of Swallowing in Patients with Acute Ischemic Stroke. J Stroke Cerebrovasc Dis 2019; 28:104297.</a></li><li><a class="nounderline abstract_t">Mann G, Hankey GJ, Cameron D. Swallowing disorders following acute stroke: prevalence and diagnostic accuracy. Cerebrovasc Dis 2000; 10:380.</a></li><li><a class="nounderline abstract_t">Cohen DL, Roffe C, Beavan J, et al. Post-stroke dysphagia: A review and design considerations for future trials. Int J Stroke 2016; 11:399.</a></li><li><a class="nounderline abstract_t">Powers WJ, Rabinstein AA, Ackerson T, et al. Guidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke 2019; 50:e344.</a></li><li><a class="nounderline abstract_t">DePippo KL, Holas MA, Reding MJ. The Burke dysphagia screening test: validation of its use in patients with stroke. Arch Phys Med Rehabil 1994; 75:1284.</a></li><li><a class="nounderline abstract_t">Leder SB, Suiter DM, Warner HL, et al. Safe initiation of oral diets in hospitalized patients based on passing a 3-ounce (90 cc) water swallow challenge protocol. QJM 2012; 105:257.</a></li><li><a class="nounderline abstract_t">Suiter DM, Sloggy J, Leder SB. Validation of the Yale Swallow Protocol: a prospective double-blinded videofluoroscopic study. Dysphagia 2014; 29:199.</a></li><li><a class="nounderline abstract_t">Hinchey JA, Shephard T, Furie K, et al. Formal dysphagia screening protocols prevent pneumonia. Stroke 2005; 36:1972.</a></li><li><a class="nounderline abstract_t">Bray BD, Smith CJ, Cloud GC, et al. The association between delays in screening for and assessing dysphagia after acute stroke, and the risk of stroke-associated pneumonia. J Neurol Neurosurg Psychiatry 2017; 88:25.</a></li><li><a class="nounderline abstract_t">Chen PC, Chuang CH, Leong CP, et al. Systematic review and meta-analysis of the diagnostic accuracy of the water swallow test for screening aspiration in stroke patients. J Adv Nurs 2016; 72:2575.</a></li><li><a class="nounderline abstract_t">Schepp SK, Tirschwell DL, Miller RM, Longstreth WT Jr. Swallowing screens after acute stroke: a systematic review. Stroke 2012; 43:869.</a></li><li><a class="nounderline abstract_t">McCullough GH, Wertz RT, Rosenbek JC. Sensitivity and specificity of clinical/bedside examination signs for detecting aspiration in adults subsequent to stroke. J Commun Disord 2001; 34:55.</a></li><li><a class="nounderline abstract_t">Daniels SK, Anderson JA, Willson PC. Valid items for screening dysphagia risk in patients with stroke: a systematic review. Stroke 2012; 43:892.</a></li><li><a class="nounderline abstract_t">Huang JF. Prevention and Management of Poststroke Complications. Continuum (Minneap Minn) 2017; 23:93.</a></li><li class="breakAll">National Institute for Health and Clinical Excellence. Stroke: The diagnosis and acute management of stroke and transient ischaemic attacks. Royal College of Physicians, London 2008. http://www.nice.org.uk/CG068 (Accessed on February 01, 2011).</li><li><a class="nounderline abstract_t">George BP, Kelly AG, Albert GP, et al. Timing of Percutaneous Endoscopic Gastrostomy for Acute Ischemic Stroke: An Observational Study From the US Nationwide Inpatient Sample. Stroke 2017; 48:420.</a></li><li><a class="nounderline abstract_t">Phipps MS, Desai RA, Wira C, Bravata DM. Epidemiology and outcomes of fever burden among patients with acute ischemic stroke. Stroke 2011; 42:3357.</a></li><li><a class="nounderline abstract_t">Greer DM, Funk SE, Reaven NL, et al. Impact of fever on outcome in patients with stroke and neurologic injury: a comprehensive meta-analysis. Stroke 2008; 39:3029.</a></li><li><a class="nounderline abstract_t">Saini M, Saqqur M, Kamruzzaman A, et al. Effect of hyperthermia on prognosis after acute ischemic stroke. Stroke 2009; 40:3051.</a></li><li><a class="nounderline abstract_t">Prasad K, Krishnan PR. Fever is associated with doubling of odds of short-term mortality in ischemic stroke: an updated meta-analysis. Acta Neurol Scand 2010; 122:404.</a></li><li><a class="nounderline abstract_t">Ginsberg MD, Busto R. Combating hyperthermia in acute stroke: a significant clinical concern. Stroke 1998; 29:529.</a></li><li><a class="nounderline abstract_t">Bogossian EG, Taccone FS. Fever management in acute brain injury. Curr Opin Crit Care 2022; 28:130.</a></li><li><a class="nounderline abstract_t">Vermeij JD, Westendorp WF, Dippel DW, et al. Antibiotic therapy for preventing infections in people with acute stroke. Cochrane Database Syst Rev 2018; 1:CD008530.</a></li><li><a class="nounderline abstract_t">Finlayson O, Kapral M, Hall R, et al. Risk factors, inpatient care, and outcomes of pneumonia after ischemic stroke. Neurology 2011; 77:1338.</a></li><li><a class="nounderline abstract_t">Kim BR, Lee J, Sohn MK, et al. Risk Factors and Functional Impact of Medical Complications in Stroke. Ann Rehabil Med 2017; 41:753.</a></li><li><a class="nounderline abstract_t">Westendorp WF, Nederkoorn PJ, Vermeij JD, et al. Post-stroke infection: a systematic review and meta-analysis. BMC Neurol 2011; 11:110.</a></li><li><a class="nounderline abstract_t">de Jonge JC, Takx RAP, Kauw F, et al. Signs of Pulmonary Infection on Admission Chest Computed Tomography Are Associated With Pneumonia or Death in Patients With Acute Stroke. Stroke 2020; 51:1690.</a></li><li><a class="nounderline abstract_t">Hilker R, Poetter C, Findeisen N, et al. Nosocomial pneumonia after acute stroke: implications for neurological intensive care medicine. Stroke 2003; 34:975.</a></li><li><a class="nounderline abstract_t">Dziewas R, Ritter M, Schilling M, et al. Pneumonia in acute stroke patients fed by nasogastric tube. J Neurol Neurosurg Psychiatry 2004; 75:852.</a></li><li><a class="nounderline abstract_t">Sellars C, Bowie L, Bagg J, et al. Risk factors for chest infection in acute stroke: a prospective cohort study. Stroke 2007; 38:2284.</a></li><li><a class="nounderline abstract_t">Herzig SJ, Doughty C, Lahoti S, et al. Acid-suppressive medication use in acute stroke and hospital-acquired pneumonia. Ann Neurol 2014; 76:712.</a></li><li><a class="nounderline abstract_t">Westendorp WF, Vermeij JD, Zock E, et al. The Preventive Antibiotics in Stroke Study (PASS): a pragmatic randomised open-label masked endpoint clinical trial. Lancet 2015; 385:1519.</a></li><li><a class="nounderline abstract_t">Kalra L, Irshad S, Hodsoll J, et al. Prophylactic antibiotics after acute stroke for reducing pneumonia in patients with dysphagia (STROKE-INF): a prospective, cluster-randomised, open-label, masked endpoint, controlled clinical trial. Lancet 2015; 386:1835.</a></li><li><a class="nounderline abstract_t">Yan T, Liu C, Li Y, et al. Prevalence and predictive factors of urinary tract infection among patients with stroke: A meta-analysis. Am J Infect Control 2018; 46:402.</a></li><li><a class="nounderline abstract_t">Sedor J, Mulholland SG. Hospital-acquired urinary tract infections associated with the indwelling catheter. Urol Clin North Am 1999; 26:821.</a></li><li><a class="nounderline abstract_t">Buckley BJR, Harrison SL, Hill A, et al. Stroke-Heart Syndrome: Incidence and Clinical Outcomes of Cardiac Complications Following Stroke. Stroke 2022; 53:1759.</a></li><li><a class="nounderline abstract_t">Hemphill JC 3rd, Greenberg SM, Anderson CS, et al. Guidelines for the Management of Spontaneous Intracerebral Hemorrhage: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke 2015; 46:2032.</a></li><li><a class="nounderline abstract_t">Alqahtani F, Aljohani S, Tarabishy A, et al. Incidence and Outcomes of Myocardial Infarction in Patients Admitted With Acute Ischemic Stroke. Stroke 2017; 48:2931.</a></li><li><a class="nounderline abstract_t">Yaghi S, Chang AD, Ricci BA, et al. Early Elevated Troponin Levels After Ischemic Stroke Suggests a Cardioembolic Source. Stroke 2018; 49:121.</a></li><li><a class="nounderline abstract_t">Khechinashvili G, Asplund K. Electrocardiographic changes in patients with acute stroke: a systematic review. Cerebrovasc Dis 2002; 14:67.</a></li><li><a class="nounderline abstract_t">Kallmünzer B, Breuer L, Kahl N, et al. Serious cardiac arrhythmias after stroke: incidence, time course, and predictors--a systematic, prospective analysis. Stroke 2012; 43:2892.</a></li><li><a class="nounderline abstract_t">Fernández-Menéndez S, García-Santiago R, Vega-Primo A, et al. Cardiac arrhythmias in stroke unit patients. Evaluation of the cardiac monitoring data. Neurologia 2016; 31:289.</a></li><li><a class="nounderline abstract_t">Vingerhoets F, Bogousslavsky J, Regli F, Van Melle G. Atrial fibrillation after acute stroke. Stroke 1993; 24:26.</a></li><li><a class="nounderline abstract_t">Morris NA, Chatterjee A, Adejumo OL, et al. The Risk of Takotsubo Cardiomyopathy in Acute Neurological Disease. Neurocrit Care 2019; 30:171.</a></li><li><a class="nounderline abstract_t">Yoshimura S, Toyoda K, Ohara T, et al. Takotsubo cardiomyopathy in acute ischemic stroke. Ann Neurol 2008; 64:547.</a></li><li><a class="nounderline abstract_t">Samuels MA. The brain-heart connection. Circulation 2007; 116:77.</a></li><li><a class="nounderline abstract_t">Chen Z, Venkat P, Seyfried D, et al. Brain-Heart Interaction: Cardiac Complications After Stroke. Circ Res 2017; 121:451.</a></li><li class="breakAll">Oppenheimer S, Norris JW. Cardiac manifestations of acute neurological lesions. In: Neurology and General Medicine, Aminoff MJ (Ed), Churchill-Livingstone, 1995. p.183.</li><li><a class="nounderline abstract_t">Chua HC, Sen S, Cosgriff RF, et al. Neurogenic ST depression in stroke. Clin Neurol Neurosurg 1999; 101:44.</a></li><li><a class="nounderline abstract_t">Jacob WA, Van Bogaert A, De Groodt-Lasseel MH. Myocardial ultrastructure and haemodynamic reactions during experimental subarachnoid haemorrhage. J Mol Cell Cardiol 1972; 4:287.</a></li><li><a class="nounderline abstract_t">Tokgözoglu SL, Batur MK, Topçuoglu MA, et al. Effects of stroke localization on cardiac autonomic balance and sudden death. Stroke 1999; 30:1307.</a></li><li><a class="nounderline abstract_t">Sander D, Klingelhöfer J. Changes of circadian blood pressure patterns after hemodynamic and thromboembolic brain infarction. Stroke 1994; 25:1730.</a></li><li><a class="nounderline abstract_t">Laowattana S, Zeger SL, Lima JA, et al. Left insular stroke is associated with adverse cardiac outcome. Neurology 2006; 66:477.</a></li><li><a class="nounderline abstract_t">Abboud H, Berroir S, Labreuche J, et al. Insular involvement in brain infarction increases risk for cardiac arrhythmia and death. Ann Neurol 2006; 59:691.</a></li><li><a class="nounderline abstract_t">Ay H, Koroshetz WJ, Benner T, et al. Neuroanatomic correlates of stroke-related myocardial injury. Neurology 2006; 66:1325.</a></li><li><a class="nounderline abstract_t">Krause T, Werner K, Fiebach JB, et al. Stroke in right dorsal anterior insular cortex Is related to myocardial injury. Ann Neurol 2017; 81:502.</a></li><li><a class="nounderline abstract_t">Koppikar S, Baranchuk A, Guzmán JC, Morillo CA. Stroke and ventricular arrhythmias. Int J Cardiol 2013; 168:653.</a></li><li><a class="nounderline abstract_t">Meyer S, Strittmatter M, Fischer C, et al. Lateralization in autonomic dysfunction in ischemic stroke involving the insular cortex. Neuroreport 2004; 15:357.</a></li><li><a class="nounderline abstract_t">Smith KE, Hachinski VC, Gibson CJ, Ciriello J. Changes in plasma catecholamine levels after insula damage in experimental stroke. Brain Res 1986; 375:182.</a></li><li><a class="nounderline abstract_t">Ruggiero DA, Mraovitch S, Granata AR, et al. A role of insular cortex in cardiovascular function. J Comp Neurol 1987; 257:189.</a></li><li><a class="nounderline abstract_t">Oppenheimer SM, Gelb A, Girvin JP, Hachinski VC. Cardiovascular effects of human insular cortex stimulation. Neurology 1992; 42:1727.</a></li><li><a class="nounderline abstract_t">Oppenheimer SM, Kedem G, Martin WM. Left-insular cortex lesions perturb cardiac autonomic tone in humans. Clin Auton Res 1996; 6:131.</a></li><li><a class="nounderline abstract_t">Zhang ZH, Rashba S, Oppenheimer SM. Insular cortex lesions alter baroreceptor sensitivity in the urethane-anesthetized rat. Brain Res 1998; 813:73.</a></li><li><a class="nounderline abstract_t">Sörös P, Hachinski V. Cardiovascular and neurological causes of sudden death after ischaemic stroke. Lancet Neurol 2012; 11:179.</a></li><li><a class="nounderline abstract_t">Balofsky A, George J, Papadakos P. Neuropulmonology. Handb Clin Neurol 2017; 140:33.</a></li><li><a class="nounderline abstract_t">Davenport RJ, Dennis MS, Warlow CP. Gastrointestinal hemorrhage after acute stroke. Stroke 1996; 27:421.</a></li><li><a class="nounderline abstract_t">O'Donnell MJ, Kapral MK, Fang J, et al. Gastrointestinal bleeding after acute ischemic stroke. Neurology 2008; 71:650.</a></li><li><a class="nounderline abstract_t">Fu J. Factors affecting the occurrence of gastrointestinal bleeding in acute ischemic stroke patients. Medicine (Baltimore) 2019; 98:e16312.</a></li><li><a class="nounderline abstract_t">Ji R, Shen H, Pan Y, et al. Risk score to predict gastrointestinal bleeding after acute ischemic stroke. BMC Gastroenterol 2014; 14:130.</a></li><li><a class="nounderline abstract_t">Taub NA, Wolfe CD, Richardson E, Burney PG. Predicting the disability of first-time stroke sufferers at 1 year. 12-month follow-up of a population-based cohort in southeast England. Stroke 1994; 25:352.</a></li><li><a class="nounderline abstract_t">Nakayama H, Jørgensen HS, Pedersen PM, et al. Prevalence and risk factors of incontinence after stroke. The Copenhagen Stroke Study. Stroke 1997; 28:58.</a></li><li><a class="nounderline abstract_t">Hankey GJ, Jamrozik K, Broadhurst RJ, et al. Five-year survival after first-ever stroke and related prognostic factors in the Perth Community Stroke Study. Stroke 2000; 31:2080.</a></li><li><a class="nounderline abstract_t">Pettersen R, Wyller TB. Prognostic significance of micturition disturbances after acute stroke. J Am Geriatr Soc 2006; 54:1878.</a></li><li><a class="nounderline abstract_t">Mehdi Z, Birns J, Bhalla A. Post-stroke urinary incontinence. Int J Clin Pract 2013; 67:1128.</a></li><li><a class="nounderline abstract_t">Brittain KR, Peet SM, Castleden CM. Stroke and incontinence. Stroke 1998; 29:524.</a></li><li><a class="nounderline abstract_t">Patel M, Coshall C, Rudd AG, Wolfe CD. Natural history and effects on 2-year outcomes of urinary incontinence after stroke. Stroke 2001; 32:122.</a></li><li><a class="nounderline abstract_t">Burney TL, Senapati M, Desai S, et al. Acute cerebrovascular accident and lower urinary tract dysfunction: a prospective correlation of the site of brain injury with urodynamic findings. J Urol 1996; 156:1748.</a></li><li><a class="nounderline abstract_t">Gelber DA, Good DC, Laven LJ, Verhulst SJ. Causes of urinary incontinence after acute hemispheric stroke. Stroke 1993; 24:378.</a></li><li><a class="nounderline abstract_t">Linsenmeyer TA. Post-CVA voiding dysfunctions: clinical insights and literature review. NeuroRehabilitation 2012; 30:1.</a></li><li><a class="nounderline abstract_t">Thomas LH, Coupe J, Cross LD, et al. Interventions for treating urinary incontinence after stroke in adults. Cochrane Database Syst Rev 2019; 2:CD004462.</a></li><li><a class="nounderline abstract_t">Minet LR, Peterson E, von Koch L, Ytterberg C. Occurrence and Predictors of Falls in People With Stroke: Six-Year Prospective Study. Stroke 2015; 46:2688.</a></li><li><a class="nounderline abstract_t">Dalli LL, Borschmann K, Cooke S, et al. Fracture Risk Increases After Stroke or Transient Ischemic Attack and Is Associated With Reduced Quality of Life. Stroke 2023; 54:2593.</a></li><li><a class="nounderline abstract_t">Ramnemark A, Nyberg L, Borssén B, et al. Fractures after stroke. Osteoporos Int 1998; 8:92.</a></li><li><a class="nounderline abstract_t">Cox R, Buckholtz B, Bradas C, et al. Risk Factors for Falls Among Hospitalized Acute Post-Ischemic Stroke Patients. J Neurosci Nurs 2017; 49:355.</a></li><li><a class="nounderline abstract_t">Jørgensen L, Jacobsen BK, Wilsgaard T, Magnus JH. Walking after stroke: does it matter? Changes in bone mineral density within the first 12 months after stroke. A longitudinal study. Osteoporos Int 2000; 11:381.</a></li><li><a class="nounderline abstract_t">Myint PK, Poole KE, Warburton EA. Hip fractures after stroke and their prevention. QJM 2007; 100:539.</a></li><li><a class="nounderline abstract_t">Winstein CJ, Stein J, Arena R, et al. Guidelines for Adult Stroke Rehabilitation and Recovery: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke 2016; 47:e98.</a></li><li><a class="nounderline abstract_t">Ayerbe L, Ayis S, Wolfe CD, Rudd AG. Natural history, predictors and outcomes of depression after stroke: systematic review and meta-analysis. Br J Psychiatry 2013; 202:14.</a></li><li><a class="nounderline abstract_t">Jørgensen TS, Wium-Andersen IK, Wium-Andersen MK, et al. Incidence of Depression After Stroke, and Associated Risk Factors and Mortality Outcomes, in a Large Cohort of Danish Patients. JAMA Psychiatry 2016; 73:1032.</a></li><li><a class="nounderline abstract_t">Towfighi A, Ovbiagele B, El Husseini N, et al. Poststroke Depression: A Scientific Statement for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke 2017; 48:e30.</a></li><li><a class="nounderline abstract_t">Chemerinski E, Robinson RG, Kosier JT. Improved recovery in activities of daily living associated with remission of poststroke depression. Stroke 2001; 32:113.</a></li><li><a class="nounderline abstract_t">House A, Knapp P, Bamford J, Vail A. Mortality at 12 and 24 months after stroke may be associated with depressive symptoms at 1 month. Stroke 2001; 32:696.</a></li><li><a class="nounderline abstract_t">Robinson RG, Price TR. Post-stroke depressive disorders: a follow-up study of 103 patients. Stroke 1982; 13:635.</a></li><li><a class="nounderline abstract_t">Carson AJ, MacHale S, Allen K, et al. Depression after stroke and lesion location: a systematic review. Lancet 2000; 356:122.</a></li><li><a class="nounderline abstract_t">Allida S, Cox KL, Hsieh CF, et al. Pharmacological, psychological, and non-invasive brain stimulation interventions for treating depression after stroke. Cochrane Database Syst Rev 2020; 1:CD003437.</a></li><li><a class="nounderline abstract_t">Watkins C, Daniels L, Jack C, et al. Accuracy of a single question in screening for depression in a cohort of patients after stroke: comparative study. BMJ 2001; 323:1159.</a></li><li><a class="nounderline abstract_t">Hinkle JL, Becker KJ, Kim JS, et al. Poststroke Fatigue: Emerging Evidence and Approaches to Management: A Scientific Statement for Healthcare Professionals From the American Heart Association. Stroke 2017; 48:e159.</a></li><li><a class="nounderline abstract_t">Paciaroni M, Acciarresi M. Poststroke Fatigue. Stroke 2019; 50:1927.</a></li><li><a class="nounderline abstract_t">De Doncker W, Dantzer R, Ormstad H, Kuppuswamy A. Mechanisms of poststroke fatigue. J Neurol Neurosurg Psychiatry 2018; 89:287.</a></li><li><a class="nounderline abstract_t">Kutlubaev MA, Duncan FH, Mead GE. Biological correlates of post-stroke fatigue: a systematic review. Acta Neurol Scand 2012; 125:219.</a></li><li><a class="nounderline abstract_t">Choi-Kwon S, Kim JS. Poststroke fatigue: an emerging, critical issue in stroke medicine. Int J Stroke 2011; 6:328.</a></li><li><a class="nounderline abstract_t">Wu S, Mead G, Macleod M, Chalder T. Model of understanding fatigue after stroke. Stroke 2015; 46:893.</a></li><li><a class="nounderline abstract_t">Wu S, Kutlubaev MA, Chun HY, et al. Interventions for post-stroke fatigue. Cochrane Database Syst Rev 2015; 2015:CD007030.</a></li><li><a class="nounderline abstract_t">Bivard A, Lillicrap T, Krishnamurthy V, et al. MIDAS (Modafinil in Debilitating Fatigue After Stroke): A Randomized, Double-Blind, Placebo-Controlled, Cross-Over Trial. Stroke 2017; 48:1293.</a></li><li><a class="nounderline abstract_t">Seners P, Turc G, Oppenheim C, Baron JC. Incidence, causes and predictors of neurological deterioration occurring within 24 h following acute ischaemic stroke: a systematic review with pathophysiological implications. J Neurol Neurosurg Psychiatry 2015; 86:87.</a></li><li><a class="nounderline abstract_t">Helleberg BH, Ellekjaer H, Indredavik B. Outcomes after Early Neurological Deterioration and Transitory Deterioration in Acute Ischemic Stroke Patients. Cerebrovasc Dis 2016; 42:378.</a></li><li><a class="nounderline abstract_t">Siegler JE, Martin-Schild S. Early Neurological Deterioration (END) after stroke: the END depends on the definition. Int J Stroke 2011; 6:211.</a></li><li><a class="nounderline abstract_t">Park TH, Lee JK, Park MS, et al. Neurologic deterioration in patients with acute ischemic stroke or transient ischemic attack. Neurology 2020; 95:e2178.</a></li><li><a class="nounderline abstract_t">Alawneh JA, Moustafa RR, Baron JC. Hemodynamic factors and perfusion abnormalities in early neurological deterioration. Stroke 2009; 40:e443.</a></li><li><a class="nounderline abstract_t">You S, Zheng D, Delcourt C, et al. Determinants of Early Versus Delayed Neurological Deterioration in Intracerebral Hemorrhage. Stroke 2019; 50:1409.</a></li><li><a class="nounderline abstract_t">Yu WM, Abdul-Rahim AH, Cameron AC, et al. The Incidence and Associated Factors of Early Neurological Deterioration After Thrombolysis: Results From SITS Registry. Stroke 2020; 51:2705.</a></li></ol></div><div id="topicVersionRevision">Topic 1093 Version 47.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10835436" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Medical complications after stroke: a multicenter study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9472888" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Medical and neurological complications of ischemic stroke: experience from the RANTTAS trial. RANTTAS Investigators.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18096834" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Medical complications in a comprehensive stroke unit and an early supported discharge service.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21868737" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : In-hospital medical complications, length of stay, and mortality among stroke unit patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19049549" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Impact of neurological and medical complications on 3-month outcomes in acute ischaemic stroke.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27515730" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Complications in the first week after stroke: a 10-year comparison.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36599695" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Age- and Sex-Specific Trends in Medical Complications After Acute Ischemic Stroke in the United States.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26166419" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Impact of Poststroke Medical Complications on 30-Day Readmission Rate.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16269630" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Dysphagia after stroke: incidence, diagnosis, and pulmonary complications.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11453569" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Initial clinical and demographic predictors of swallowing impairment following acute stroke.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/37596008" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : The assessment of dysphagia after stroke: state of the art and future directions.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31358355" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Initial National Institute of Health Stroke Scale to Early Predict the Improvement of Swallowing in Patients with Acute Ischemic Stroke.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10971024" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Swallowing disorders following acute stroke: prevalence and diagnostic accuracy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27006423" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Post-stroke dysphagia: A review and design considerations for future trials.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31662037" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Guidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7993165" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : The Burke dysphagia screening test: validation of its use in patients with stroke.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22006561" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Safe initiation of oral diets in hospitalized patients based on passing a 3-ounce (90 cc) water swallow challenge protocol.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24026519" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Validation of the Yale Swallow Protocol: a prospective double-blinded videofluoroscopic study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16109909" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Formal dysphagia screening protocols prevent pneumonia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27298147" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : The association between delays in screening for and assessing dysphagia after acute stroke, and the risk of stroke-associated pneumonia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27237447" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Systematic review and meta-analysis of the diagnostic accuracy of the water swallow test for screening aspiration in stroke patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22156697" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Swallowing screens after acute stroke: a systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11322570" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Sensitivity and specificity of clinical/bedside examination signs for detecting aspiration in adults subsequent to stroke.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22308250" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Valid items for screening dysphagia risk in patients with stroke: a systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28157746" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Prevention and Management of Poststroke Complications.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28157746" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Prevention and Management of Poststroke Complications.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27965430" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Timing of Percutaneous Endoscopic Gastrostomy for Acute Ischemic Stroke: An Observational Study From the US Nationwide Inpatient Sample.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21980196" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Epidemiology and outcomes of fever burden among patients with acute ischemic stroke.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18723420" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Impact of fever on outcome in patients with stroke and neurologic injury: a comprehensive meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19644066" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Effect of hyperthermia on prognosis after acute ischemic stroke.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20199523" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Fever is associated with doubling of odds of short-term mortality in ischemic stroke: an updated meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9472901" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Combating hyperthermia in acute stroke: a significant clinical concern.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35058405" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Fever management in acute brain injury.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29355906" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Antibiotic therapy for preventing infections in people with acute stroke.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21940613" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Risk factors, inpatient care, and outcomes of pneumonia after ischemic stroke.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29201813" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Risk Factors and Functional Impact of Medical Complications in Stroke.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21933425" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Post-stroke infection: a systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32397939" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Signs of Pulmonary Infection on Admission Chest Computed Tomography Are Associated With Pneumonia or Death in Patients With Acute Stroke.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12637700" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Nosocomial pneumonia after acute stroke: implications for neurological intensive care medicine.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15145999" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Pneumonia in acute stroke patients fed by nasogastric tube.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17569875" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Risk factors for chest infection in acute stroke: a prospective cohort study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25164323" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Acid-suppressive medication use in acute stroke and hospital-acquired pneumonia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25612858" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : The Preventive Antibiotics in Stroke Study (PASS): a pragmatic randomised open-label masked endpoint clinical trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26343840" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Prophylactic antibiotics after acute stroke for reducing pneumonia in patients with dysphagia (STROKE-INF): a prospective, cluster-randomised, open-label, masked endpoint, controlled clinical trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29153643" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Prevalence and predictive factors of urinary tract infection among patients with stroke: A meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10584622" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Hospital-acquired urinary tract infections associated with the indwelling catheter.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35354300" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Stroke-Heart Syndrome: Incidence and Clinical Outcomes of Cardiac Complications Following Stroke.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26022637" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Guidelines for the Management of Spontaneous Intracerebral Hemorrhage: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29018137" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Incidence and Outcomes of Myocardial Infarction in Patients Admitted With Acute Ischemic Stroke.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29167390" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Early Elevated Troponin Levels After Ischemic Stroke Suggests a Cardioembolic Source.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12187009" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Electrocardiographic changes in patients with acute stroke: a systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22961962" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Serious cardiac arrhythmias after stroke: incidence, time course, and predictors--a systematic, prospective analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25976944" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Cardiac arrhythmias in stroke unit patients. Evaluation of the cardiac monitoring data.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8418546" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Atrial fibrillation after acute stroke.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30094686" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : The Risk of Takotsubo Cardiomyopathy in Acute Neurological Disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18688801" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Takotsubo cardiomyopathy in acute ischemic stroke.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17606855" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : The brain-heart connection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28775014" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Brain-Heart Interaction: Cardiac Complications After Stroke.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28775014" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Brain-Heart Interaction: Cardiac Complications After Stroke.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10350204" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Neurogenic ST depression in stroke.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/5052586" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Myocardial ultrastructure and haemodynamic reactions during experimental subarachnoid haemorrhage.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10390300" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Effects of stroke localization on cardiac autonomic balance and sudden death.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8073451" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Changes of circadian blood pressure patterns after hemodynamic and thromboembolic brain infarction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16505298" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Left insular stroke is associated with adverse cardiac outcome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16566012" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Insular involvement in brain infarction increases risk for cardiac arrhythmia and death.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16525122" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Neuroanatomic correlates of stroke-related myocardial injury.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28253544" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Stroke in right dorsal anterior insular cortex Is related to myocardial injury.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23602297" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Stroke and ventricular arrhythmias.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15076768" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Lateralization in autonomic dysfunction in ischemic stroke involving the insular cortex.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3719356" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : Changes in plasma catecholamine levels after insula damage in experimental stroke.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3571525" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : A role of insular cortex in cardiovascular function.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1513461" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : Cardiovascular effects of human insular cortex stimulation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8832121" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : Left-insular cortex lesions perturb cardiac autonomic tone in humans.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9824672" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : Insular cortex lesions alter baroreceptor sensitivity in the urethane-anesthetized rat.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22265213" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : Cardiovascular and neurological causes of sudden death after ischaemic stroke.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28187807" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : Neuropulmonology.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8610306" id="rid76" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>77 : Gastrointestinal hemorrhage after acute stroke.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18685137" id="rid77" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>78 : Gastrointestinal bleeding after acute ischemic stroke.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31305417" id="rid78" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>79 : Factors affecting the occurrence of gastrointestinal bleeding in acute ischemic stroke patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25059927" id="rid79" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>80 : Risk score to predict gastrointestinal bleeding after acute ischemic stroke.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8303744" id="rid80" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>81 : Predicting the disability of first-time stroke sufferers at 1 year. 12-month follow-up of a population-based cohort in southeast England.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8996489" id="rid81" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>82 : Prevalence and risk factors of incontinence after stroke. The Copenhagen Stroke Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10978033" id="rid82" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>83 : Five-year survival after first-ever stroke and related prognostic factors in the Perth Community Stroke Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17198493" id="rid83" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>84 : Prognostic significance of micturition disturbances after acute stroke.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23834208" id="rid84" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>85 : Post-stroke urinary incontinence.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9472900" id="rid85" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>86 : Stroke and incontinence.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11136926" id="rid86" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>87 : Natural history and effects on 2-year outcomes of urinary incontinence after stroke.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8863586" id="rid87" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>88 : Acute cerebrovascular accident and lower urinary tract dysfunction: a prospective correlation of the site of brain injury with urodynamic findings.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8446973" id="rid88" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>89 : Causes of urinary incontinence after acute hemispheric stroke.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22349836" id="rid89" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>90 : Post-CVA voiding dysfunctions: clinical insights and literature review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30706461" id="rid90" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>91 : Interventions for treating urinary incontinence after stroke in adults.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26243230" id="rid91" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>92 : Occurrence and Predictors of Falls in People With Stroke: Six-Year Prospective Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/37581266" id="rid92" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>93 : Fracture Risk Increases After Stroke or Transient Ischemic Attack and Is Associated With Reduced Quality of Life.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9692083" id="rid93" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>94 : Fractures after stroke.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29117031" id="rid94" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>95 : Risk Factors for Falls Among Hospitalized Acute Post-Ischemic Stroke Patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10912838" id="rid95" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>96 : Walking after stroke: does it matter? Changes in bone mineral density within the first 12 months after stroke. A longitudinal study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17693418" id="rid96" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>97 : Hip fractures after stroke and their prevention.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27145936" id="rid97" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>98 : Guidelines for Adult Stroke Rehabilitation and Recovery: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23284148" id="rid98" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>99 : Natural history, predictors and outcomes of depression after stroke: systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27603000" id="rid99" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>100 : Incidence of Depression After Stroke, and Associated Risk Factors and Mortality Outcomes, in a Large Cohort of Danish Patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27932603" id="rid100" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>101 : Poststroke Depression: A Scientific Statement for Healthcare Professionals From the American Heart Association/American Stroke Association.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11136924" id="rid101" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>102 : Improved recovery in activities of daily living associated with remission of poststroke depression.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11239189" id="rid102" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>103 : Mortality at 12 and 24 months after stroke may be associated with depressive symptoms at 1 month.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7123596" id="rid103" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>104 : Post-stroke depressive disorders: a follow-up study of 103 patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10963248" id="rid104" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>105 : Depression after stroke and lesion location: a systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31989584" id="rid105" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>106 : Pharmacological, psychological, and non-invasive brain stimulation interventions for treating depression after stroke.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11711407" id="rid106" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>107 : Accuracy of a single question in screening for depression in a cohort of patients after stroke: comparative study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28546322" id="rid107" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>108 : Poststroke Fatigue: Emerging Evidence and Approaches to Management: A Scientific Statement for Healthcare Professionals From the American Heart Association.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31195940" id="rid108" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>109 : Poststroke Fatigue.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28939684" id="rid109" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>110 : Mechanisms of poststroke fatigue.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22070461" id="rid110" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>111 : Biological correlates of post-stroke fatigue: a systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21745344" id="rid111" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>112 : Poststroke fatigue: an emerging, critical issue in stroke medicine.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25649798" id="rid112" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>113 : Model of understanding fatigue after stroke.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26133313" id="rid113" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>114 : Interventions for post-stroke fatigue.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28404841" id="rid114" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>115 : MIDAS (Modafinil in Debilitating Fatigue After Stroke): A Randomized, Double-Blind, Placebo-Controlled, Cross-Over Trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24970907" id="rid115" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>116 : Incidence, causes and predictors of neurological deterioration occurring within 24 h following acute ischaemic stroke: a systematic review with pathophysiological implications.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27351585" id="rid116" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>117 : Outcomes after Early Neurological Deterioration and Transitory Deterioration in Acute Ischemic Stroke Patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21557807" id="rid117" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>118 : Early Neurological Deterioration (END) after stroke: the END depends on the definition.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32817184" id="rid118" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>119 : Neurologic deterioration in patients with acute ischemic stroke or transient ischemic attack.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19390076" id="rid119" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>120 : Hemodynamic factors and perfusion abnormalities in early neurological deterioration.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31136288" id="rid120" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>121 : Determinants of Early Versus Delayed Neurological Deterioration in Intracerebral Hemorrhage.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32811373" id="rid121" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>122 : The Incidence and Associated Factors of Early Neurological Deterioration After Thrombolysis: Results From SITS Registry.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
